Tag: biomedical
-
Resistant Fungus Treatment Shown Effective in Early Results
Results from a clinical trial show an experimental anti-fungal drug effective in 2 cases of Candida auris infections, a fungus resistant to most other drugs.
-
Smartwatch Monitor Boosts Parkinson’s Care
A university in the U.K. designed a home-based care plan for people with Parkinson’s disease that uses a smartwatch device to monitor their conditions.
-
FDA Expands Evidence Project to Replace Trials
The Food and Drug Administration is expanding a demonstration project with a Boston teaching hospital that tests the value of real world evidence to replace some clinical trials.
-
FDA Approves Single Dual-Drug Pill for HIV
The Food and Drug Administration approved a daily pill with 2 drugs to lower viral loads in people with HIV, but who have not yet taken other HIV drugs.
-
Biotechs Partner on Gene Silencing in $1.1B Deal
Two biotechnology companies plan to develop new therapies mainly for eye and neurological diseases that silence genes responsible for those conditions.
-
Process Devised for Sensor-Fitted Personal Prosthetics
Biomedical engineers developed techniques to produce low-cost personalized electronic-enabled prosthetic devices for people with limb loss.
-
NIH Launches Universal Flu Vaccine Trial
A clinical trial testing a vaccine designed to prevent infections from many influenza strains is underway at National Institutes of Health.
-
Virtual Reality Harnessed to View Inside Blood Vessels
A medical team demonstrated the feasibility of virtual reality to visualize and guide a catheter inside blood vessels through a three-dimensional human model.
-
Biotechs Join Forces for Off-the-Shelf Stem Cells
Two biotechnology enterprises working in genome editing and regenerative medicine are sharing their technologies to develop off-the-shelf cell therapies.
-
Radiation-Antibody Biotech Raises $105M in Venture Funds
A company creating cancer treatments that combine radiation therapy with the targeting of synthetic antibodies is raising $105 million in its second round of venture financing.